FDA Scientific Advisory Committee Discusses 22nd Century Group’s Reduced Nicotine Cigarettes
22nd Century Group, Inc (XXII)
NASDAQ:AMEX Investor Relations:
xxiicentury.com
Company Research
Source: Business Wire
22nd Century Group and FDA presented information regarding 22nd Century’s Modified Risk Tobacco Product marketing application for its proprietary VLN® and VLN® Menthol Reduced Nicotine Content Cigarettes WILLIAMSVILLE, N.Y.--(BUSINESS WIRE)--22nd Century Group, Inc. (NYSE American: XXII) — a plant biotechnology company that is a leader in reduced nicotine tobacco and hemp/cannabis plant research — met on Friday, February 14, 2020 with the U.S. Food and Drug Administration’s Tobacco Product Scientific Advisory Committee (TPSAC) to present the Company’s Modified Risk Tobacco Product (MRTP) application for its proprietary, reduced nicotine content cigarettes. This meeting was the first time that TPSAC considered an MRTP application for a modified exposure claim and also TPSAC's first discussion of an application for a combustible tobacco product.“Our team was extremely well-prepared for the meeting and performed exceptionally well,” said Mike Zercher, President of 22nd Century Group.
Show less
Read more
Impact Snapshot
Event Time:
XXII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XXII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XXII alerts
High impacting 22nd Century Group, Inc news events
Weekly update
A roundup of the hottest topics
XXII
News
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group Inc (XXII) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]Yahoo! Finance
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- 22nd Century Group, Inc. (NASDAQ: XXII) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
XXII
Earnings
- 5/15/24 - Beat
XXII
Sec Filings
- 11/14/24 - Form SC
- 11/12/24 - Form 8-K
- 11/12/24 - Form 10-Q
- XXII's page on the SEC website